StemCells to Acquire UK's Stem Cell Sciences for Up to $4.85M to Build Drug-Discovery Play

StemCells plans to invest in Stem Cell Sciences' operational facilities in Cambridge, UK, in order to provide cell-based assay services to the drug discovery industry there, according to SCS' CEO.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.